Skip to main content
. 2023 Nov 8;13:19399. doi: 10.1038/s41598-023-46924-0

Figure 1.

Figure 1

A flow diagram of this study. Combination. CTx: Gemcitabine plus Nab-Paclitaxel, FOLFIRINOX, Gemcitabine plus S-1, Gemcitabine plus Erlotinib, Fluorouracil/l-leucovorin plus oxaliplatin, Mono CTx: Gemcitabine, S-1.